hydroxyurea has been researched along with Erythrocytosis in 31 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient given hydroxyurea for polycythemia suddenly developed severe interstitial pneumonia with fever and hypoxemia." | 7.70 | [Acute interstitial pneumopathy with fever caused by hydroxyurea]. ( Blanc, PL; Hammoud, H; Joasson, JM; Matussière, Y, 2000) |
| "Twenty-one polycythemia vera, 28 essential thrombocythemia, eight secondary erythrocytosis, and 30 controls were studied." | 5.37 | Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia. ( Albizua, E; Ayala, R; Barrio, S; Besses, C; Espinet, B; Florensa, L; Gallardo, M; Jimenez, A; Martinez-Lopez, J; Puigdecanet, E; Rapado, I; Rueda, D; Sanchez-Espiridion, B, 2011) |
| "Hydroxyurea is a common cancer chemotherapy agent that inhibits ribonucleotide reductase, an enzyme essential to DNA synthesis." | 5.30 | Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic factor? ( García-Aranda, JM; Moreno, JC; Vélez, A, 1999) |
| "Leg ulcers are a relatively frequent problem in patients with myeloproliferative disorders under treatment with hydroxyurea (HU)." | 4.80 | Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related? ( Bader, U; Banyai, M; Böni, R; Burg, G; Hafner, J, 2000) |
| "A patient given hydroxyurea for polycythemia suddenly developed severe interstitial pneumonia with fever and hypoxemia." | 3.70 | [Acute interstitial pneumopathy with fever caused by hydroxyurea]. ( Blanc, PL; Hammoud, H; Joasson, JM; Matussière, Y, 2000) |
| "In idiopathic myelofibrosis (IMF) PDGF is considered to be one of the growth factors responsible for the development of bone marrow fibrosis." | 2.71 | Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis. ( Birgens, H; Bjerrum, OW; Clausen, NT; Hansen, PB; Hasselbalch, HC; Jensen, BA; Ralfkiaer, E; Therkildsen, MH, 2003) |
| "Polycythemia vera (PV) and essential thrombocythemia (ET) are chronic disorders for which there are no medical cures." | 2.41 | Other secondary sequelae of treatments for myeloproliferative disorders. ( Gilbert, HS, 2002) |
| "Default of therapy for polycythemia is associated with a profound risk of recurrent strokes requiring patient education and support to prevent the devastating consequence of this modifiable but rare cause of stroke." | 1.51 | Recurrent Stroke in a Ghanaian Patient With Polycythemia. ( Berchie, PO; Opare-Sem, OK; Ovbiagele, B; Sarfo, FS, 2019) |
| "Twenty-one polycythemia vera, 28 essential thrombocythemia, eight secondary erythrocytosis, and 30 controls were studied." | 1.37 | Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia. ( Albizua, E; Ayala, R; Barrio, S; Besses, C; Espinet, B; Florensa, L; Gallardo, M; Jimenez, A; Martinez-Lopez, J; Puigdecanet, E; Rapado, I; Rueda, D; Sanchez-Espiridion, B, 2011) |
| "The underlying cause was polycythemia rubra vera and osteomyolofibrosis." | 1.35 | [Budd-Chiari syndrome--from diagnosis to treatment--case reports]. ( Dybowska, D; Kozielewicz, D; Smukalska, E, 2008) |
| "Hydroxyurea seems to be an eddicient there alternative therapy for seconday polycythemia caused by incurable cyantic congenital heart disease." | 1.34 | [Chemotherapy against polycythemia due to a cyanotic congenital heart disease in adults. One case report]. ( Békir, S; Ben Romdhane, N; Boussaada, R; Mechmèche, R, 2007) |
| "Diagnosis of polycythemia vera during pregnancy is a very difficult task due to physiologic changes occurring during gestation." | 1.32 | [Polycythemia vera and pregnancy]. ( Beillat, T; Dreyfus, M; Macro, M, 2004) |
| "Hydroxyurea is a common cancer chemotherapy agent that inhibits ribonucleotide reductase, an enzyme essential to DNA synthesis." | 1.30 | Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic factor? ( García-Aranda, JM; Moreno, JC; Vélez, A, 1999) |
| "Use of this test in cancer patients undergoing either chemotherapy or radiation therapy revealed evidence of early negative B12 balance that in some instances was induced by the treatment itself." | 1.29 | New assay for the rapid determination of plasma holotranscobalamin II levels: preliminary evaluation in cancer patients. ( Amin, J; Flener, V; Ramos, M; Tisman, G; Vanyo, L; Vu, T, 1993) |
| "The slower appearance of CFU-E in polycythemia was corrected by the injection of erythropoietin (Ep) 8 h prior to sacrifice, but an absolute increase in colony number only occurred when Ep was injected 24 h previously." | 1.27 | Studies on the kinetics of the erythroid colony-forming cell. ( Lipschitz, DA; Udupa, KB, 1986) |
| "Severe polycythemia was found in 3 dogs with PCV 68% to 70%." | 1.26 | Diagnosis of canine primary polycythemia and management with hydroxyurea. ( Peterson, ME; Randolph, JF, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (25.81) | 18.7374 |
| 1990's | 7 (22.58) | 18.2507 |
| 2000's | 11 (35.48) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berchie, PO | 1 |
| Sarfo, FS | 1 |
| Opare-Sem, OK | 1 |
| Ovbiagele, B | 1 |
| Ruella, M | 1 |
| Salmoiraghi, S | 1 |
| Risso, A | 1 |
| Carobbio, A | 1 |
| Buttiglieri, S | 1 |
| Spatola, T | 1 |
| Sivera, P | 1 |
| Ricca, I | 1 |
| Barbui, T | 1 |
| Tarella, C | 1 |
| Rambaldi, A | 1 |
| Kozielewicz, D | 1 |
| Smukalska, E | 1 |
| Dybowska, D | 1 |
| Albizua, E | 1 |
| Gallardo, M | 1 |
| Barrio, S | 1 |
| Rapado, I | 1 |
| Jimenez, A | 1 |
| Ayala, R | 1 |
| Rueda, D | 1 |
| Sanchez-Espiridion, B | 1 |
| Puigdecanet, E | 1 |
| Espinet, B | 1 |
| Florensa, L | 1 |
| Besses, C | 1 |
| Martinez-Lopez, J | 1 |
| Kouroupi, E | 1 |
| Cassinat, B | 1 |
| Schlageter, MH | 1 |
| Dosquet, C | 1 |
| Kiladjian, JJ | 1 |
| Chomienne, C | 1 |
| Gemünden, C | 1 |
| Gerber, B | 1 |
| Hasselbalch, HC | 1 |
| Bjerrum, OW | 1 |
| Jensen, BA | 1 |
| Clausen, NT | 1 |
| Hansen, PB | 1 |
| Birgens, H | 1 |
| Therkildsen, MH | 1 |
| Ralfkiaer, E | 1 |
| Beillat, T | 1 |
| Macro, M | 1 |
| Dreyfus, M | 1 |
| Rossi, D | 1 |
| Cortini, F | 1 |
| Deambrogi, C | 1 |
| Barbieri, C | 1 |
| Cerri, M | 1 |
| Franceschetti, S | 1 |
| Conconi, A | 1 |
| Capello, D | 1 |
| Gaidano, G | 1 |
| Reiss, UM | 1 |
| Bensimhon, P | 1 |
| Zimmerman, SA | 1 |
| Ware, RE | 1 |
| Tomson, N | 1 |
| Sterling, JC | 1 |
| Boussaada, R | 1 |
| Békir, S | 1 |
| Ben Romdhane, N | 1 |
| Mechmèche, R | 1 |
| Tutaeva, V | 1 |
| Misurin, AV | 1 |
| Michiels, JJ | 1 |
| Rozenberg, JM | 1 |
| Sokolova, MA | 1 |
| Ivanova, VL | 1 |
| Kolosheinova, TI | 1 |
| Manakova, TE | 1 |
| Levina, AA | 1 |
| Semenova, EA | 1 |
| Khoroshko, ND | 1 |
| Pavlovíc-Kentera, V | 1 |
| Milenković, P | 1 |
| Seidel, HJ | 1 |
| Kreja, L | 1 |
| Peterson, ME | 1 |
| Randolph, JF | 1 |
| Najean, Y | 2 |
| Rain, JD | 1 |
| Toubert, ME | 1 |
| Vu, T | 1 |
| Amin, J | 1 |
| Ramos, M | 1 |
| Flener, V | 1 |
| Vanyo, L | 1 |
| Tisman, G | 1 |
| Dapling, RB | 1 |
| Snowden, JA | 1 |
| West, J | 1 |
| Talbot, JF | 1 |
| Nelson, ME | 1 |
| Greaves, M | 1 |
| van der Klooster, JM | 1 |
| Sucec, PM | 1 |
| Stiegelis, WF | 1 |
| Hagenbeek, A | 1 |
| Vélez, A | 1 |
| García-Aranda, JM | 1 |
| Moreno, JC | 1 |
| Bader, U | 1 |
| Banyai, M | 1 |
| Böni, R | 1 |
| Burg, G | 1 |
| Hafner, J | 1 |
| Blanc, PL | 1 |
| Joasson, JM | 1 |
| Hammoud, H | 1 |
| Matussière, Y | 1 |
| Gilbert, HS | 1 |
| McCuskey, RS | 1 |
| Meineke, HA | 1 |
| Rencricca, NJ | 1 |
| Morse, BS | 1 |
| Monette, FC | 1 |
| Howard, D | 1 |
| Stohlman, F | 1 |
| Legrand, M | 1 |
| Poirier, O | 1 |
| Senechal, A | 1 |
| Arrago, JP | 1 |
| Page, RL | 1 |
| Stiff, ME | 1 |
| McEntee, MC | 1 |
| Walter, LG | 1 |
| Hocking, WG | 1 |
| Golde, DW | 1 |
| Udupa, KB | 1 |
| Lipschitz, DA | 1 |
| Walterspiel, JN | 1 |
| Buchanan, GR | 1 |
| Schad, GA | 1 |
| Carpentieri, U | 1 |
4 reviews available for hydroxyurea and Erythrocytosis
| Article | Year |
|---|---|
Fever caused by hydroxyurea: a report of three cases and review of the literature.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Female; Fever; Humans; Hydroxyurea; Male; Middle Age | 1997 |
Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related?
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Female; Follow-Up Studies; Humans; Hydroxyurea; Leg | 2000 |
Other secondary sequelae of treatments for myeloproliferative disorders.
Topics: Antineoplastic Agents; Fibrinolytic Agents; Humans; Hydroxyurea; Immunologic Factors; Interferon-alp | 2002 |
Polycythemia: evaluation and management.
Topics: Adult; Aged; Bloodletting; Humans; Hydroxyurea; Middle Aged; Polycythemia; Polycythemia Vera | 1989 |
2 trials available for hydroxyurea and Erythrocytosis
| Article | Year |
|---|---|
Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Female; | 2003 |
[Treatment of polycythemia with 32P with or without hydroxyurea maintenance therapy. Preliminary results in 237 elderly and high vascular risk subjects studied since 1980].
Topics: Age Factors; Aged; Carcinoma; Cardiovascular Diseases; Female; Humans; Hydroxyurea; Injections, Intr | 1993 |
25 other studies available for hydroxyurea and Erythrocytosis
| Article | Year |
|---|---|
Recurrent Stroke in a Ghanaian Patient With Polycythemia.
Topics: Aphasia, Broca; Aspirin; Clopidogrel; Ghana; Humans; Hydroxyurea; Infarction, Middle Cerebral Artery | 2019 |
Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Child; Child, Preschool; Clone Cells; Female | 2013 |
[Budd-Chiari syndrome--from diagnosis to treatment--case reports].
Topics: Adult; Anticoagulants; Budd-Chiari Syndrome; Female; Humans; Hydroxyurea; Polycythemia; Primary Myel | 2008 |
Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Gene Expression Profiling; Gene Expres | 2011 |
Coexistence of a myeloproliferative disorder and secondary polycythemia in the same patient.
Topics: Aged, 80 and over; Comorbidity; Drug Resistance; Erythropoiesis; Erythropoietin; Humans; Hydroxyurea | 2012 |
[Polycythemia vera].
Topics: Aged; Algorithms; Alleles; Bone Marrow Examination; Diagnosis, Differential; Erythropoietin; Female; | 2012 |
[Polycythemia vera and pregnancy].
Topics: Adult; Antisickling Agents; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hum | 2004 |
Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Aspirin; Bone Marrow; Diagnosis, Differenti | 2007 |
Hydroxyurea therapy for management of secondary erythrocytosis in cyanotic congenital heart disease.
Topics: Adolescent; Adult; Female; Heart Defects, Congenital; Humans; Hydroxyurea; Male; Polycythemia | 2007 |
Hydroxycarbamide: a treatment for lichen sclerosus?
Topics: Aged; Antineoplastic Agents; Female; Humans; Hydroxyurea; Polycythemia; Treatment Outcome; Vulvar Li | 2007 |
[Chemotherapy against polycythemia due to a cyanotic congenital heart disease in adults. One case report].
Topics: Adult; Erythrocytes; Follow-Up Studies; Heart Defects, Congenital; Heart Septal Defects, Ventricular | 2007 |
Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea.
Topics: Diagnosis, Differential; GPI-Linked Proteins; Humans; Hydroxyurea; Interferon-alpha; Isoantigens; Ja | 2007 |
Effect of erythropoietin on erythropoietin-responsive cell regeneration in polycythemic mice treated with cyclophosphamide.
Topics: Animals; Cell Division; Cyclophosphamide; Erythropoiesis; Erythropoietin; Female; Hematopoietic Stem | 1981 |
Studies on the resistance of the C57B1/6 mouse strain to the polycythemia-inducing strain of the Friend virus (FV-P).
Topics: Animals; Bone Marrow Transplantation; Cell Division; Endotoxins; Female; Friend murine leukemia viru | 1981 |
Diagnosis of canine primary polycythemia and management with hydroxyurea.
Topics: Animals; Dog Diseases; Dogs; Female; Hydroxyurea; Male; Polycythemia | 1982 |
New assay for the rapid determination of plasma holotranscobalamin II levels: preliminary evaluation in cancer patients.
Topics: Adsorption; Chromatography; Glass; Hematologic Tests; Homocysteine; Humans; Hydroxyurea; Microsphere | 1993 |
The microvasculature in myeloproliferative disease. A study using retinal fluorescein angiography.
Topics: Adult; Aged; Aged, 80 and over; Allergens; Antineoplastic Agents; Arterial Occlusive Diseases; Aspir | 1996 |
Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic factor?
Topics: Animals; Dogs; Female; Humans; Hydroxyurea; Leg Ulcer; Middle Aged; Nucleic Acid Synthesis Inhibitor | 1999 |
[Acute interstitial pneumopathy with fever caused by hydroxyurea].
Topics: Aged; Aged, 80 and over; Female; Fever; Follow-Up Studies; Humans; Hydroxyurea; Lung Diseases, Inter | 2000 |
Studies of the hemopoietic microenvironment. V. Erythropoietin-induced release of vasoactive substance(s) from erythropoietin-responsive stem cells (39902).
Topics: Animals; Busulfan; Erythropoiesis; Erythropoietin; Female; Hematocrit; Hematopoietic Stem Cells; Hyd | 1977 |
Hydroxyurea-induced erythroid differentiation.
Topics: Animals; Antibodies; Cell Count; Erythropoietin; Female; Hematocrit; Hematopoietic Stem Cells; Hydro | 1975 |
Clinical significance of serum pro-collagen III in chronic myeloproliferative disorders.
Topics: Aged; Bloodletting; Humans; Hydroxyurea; Myeloproliferative Disorders; Polycythemia; Polycythemia Ve | 1990 |
Transient glomerulonephropathy associated with primary erythrocytosis in a dog.
Topics: Animals; Bloodletting; Combined Modality Therapy; Dog Diseases; Dogs; Doxorubicin; Female; Hydroxyur | 1990 |
Studies on the kinetics of the erythroid colony-forming cell.
Topics: Anemia; Animals; Blood Sedimentation; Bone Marrow Cells; Cells, Cultured; Colony-Forming Units Assay | 1986 |
Erythropoietin-induced congenital erythrocytosis: treatment with myelosuppressive agents and hookworm infestation.
Topics: Bloodletting; Erythropoietin; Female; Hookworm Infections; Humans; Hydroxyurea; Infant; Methotrexate | 1985 |